Latanoprost (0.005%) trials for Hypertension

All Latanoprost (0.005%) trials · All Hypertension trials

Phase breakdown

Recruiting trials studying Latanoprost (0.005%) for Hypertension

• A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital
  NCT07310719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
  NCT04401982 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Optic Nerve Head Strain in Non-glaucoma Subjects
  NCT07425535 · Phase: Early Phase 1 · Ages: 30 Years to 90 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Latanoprost (0.005%) for Hypertension?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.